Informations sur le produit
MK-7246-d3 is a pancreas-selective β-cell receptor agonist that has been shown to have efficacy in the treatment of type 1 diabetes. The compound is able to inhibit the release of histamine from eosinophilic cells, which may be due to its ability to bind to histamine H1 receptors and inhibit calcium influx. MK-7246-d3 has also been shown to decrease acid secretion and increase bicarbonate secretion. These effects on the pancreas may be due to its ability to act as a potent antagonist at the gastric histamine H2 receptor. MK-7246-d3 has not yet been tested in humans but has shown promising results in vitro and in vivo animal models. This drug is also being evaluated for use in other diseases, such as chronic obstructive pulmonary disease, asthma, and rhinosinusitis.
Propriétés chimiques
Question d’ordre technique sur : 3D-TYB91862 MK-7246-d3
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
